R P Mischak

A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines.

M C Hancock, Tiffany Chan, Pam Toy et al. · PubMed · 1991 · 226 citations

Medicine, Oncology, Pharmacology +15

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.

Lynn E. S̄pitler, Maguy Del Rio, Archie Khentigan et al. · PubMed · 1987 · 215 citations

Medicine, Oncology, Pharmacology +11

A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo

Lichuan Yang, Shuei Sugama, R P Mischak et al. · Neurobiology of Disease · 2004 · 81 citations · Full text

Life Sciences, Pharmacology, Toxicology +12

Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial.

Ruth Oratz, Speyer Jl, Wernz Jc et al. · PubMed · 1990 · 55 citations

Medicine, Oncology, Pharmacology +15

Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients

Scott Harkonen, Patrick J. Scannon, R P Mischak et al. · Antimicrobial Agents and Chemotherapy · 1988 · 52 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14